Brind.

Cana Laboratories, a subsidiary of Cosmos Health, manufactures products for Pharmex, which serves markets across Europe.

4 reports, 3 independent Updated Mon 00:00
Mostly repetition
Reports
4
Developments
2
Repetition
75%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Cana Laboratories, a subsidiary of Cosmos Health, manufactures products for Pharmex, which serves markets across Europe.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Cana Laboratories secured a five-year contract with Viofar, while Cosmos Health Inc. maintains ownership of the subsidiary.Sub-event
  2. Cosmos Health owns Cana, which manufactures products for Pharmex serving European markets.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
1 more outlet ran the same wire story